The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 358:2516-2518 June 5, 2008 Number 23
NextNext

Bare-Metal versus Drug-Eluting Coronary Stents

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Marroquin, O. C.
-PubMed Citation
To the Editor: Marroquin et al. (Jan. 24 issue)1 attempt to address the lack of evidence regarding off-label use of drug-eluting stents. However, their use of a historical comparison group that predated the group with drug-eluting stents by up to 9 years raises major concerns. First, the control group that received bare-metal stents included all patients who received a stent between 1997 and 2002. Patients treated with bare-metal stents in 2004 and 2006 were considered to be highly selected and were excluded from the study. However, the group with drug-eluting stents that made up the remaining 78% of patients who . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.